Cutting edge: delay and reversal of T cell tolerance by intratumoral injection of antigen-loaded dendritic cells in an autochthonous tumor model.
about
Differential requirement for CD70 and CD80/CD86 in dendritic cell-mediated activation of tumor-tolerized CD8 T cells.Whole-body irradiation increases the magnitude and persistence of adoptively transferred T cells associated with tumor regression in a mouse model of prostate cancerNeem leaf glycoprotein activates CD8(+) T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcomaPersistence of tumor-infiltrating CD8 T cells is tumor-dependent but antigen-independentCell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancerRole of dendritic cells in the regulation of antitumor immunityLocal administration of TLR ligands rescues the function of tumor-infiltrating CD8 T cells and enhances the antitumor effect of lentivector immunizationXiao-Ai-Ping, a TCM Injection, Enhances the Antigrowth Effects of Cisplatin on Lewis Lung Cancer Cells through Promoting the Infiltration and Function of CD8(+) T Lymphocytes.Theoretical modeling techniques and their impact on tumor immunology.Phase I trial of preoperative intratumoral injection of immature dendritic cells and OK-432 for resectable pancreatic cancer patients.Therapeutic response in patients with advanced malignancies treated with combined dendritic cell-activated T cell based immunotherapy and intensity-modulated radiotherapy
P2860
Q33768093-8FD97482-1C3A-4757-A06B-7F61FCF25DEEQ34016750-549840A0-0140-4E74-9B88-80AEC55C1313Q34550822-CE577600-4191-470C-8F2C-F63E10664813Q36053040-BBC9884B-EAAE-445A-B965-A759C158064AQ36303665-8CE614D1-2B45-41D5-BEAD-9D7FE01474F1Q36845842-119CE769-3818-4006-BF0B-145C1FEE4439Q36863949-A185D390-3A02-49B6-B4DF-E3D6559B9B2DQ37061399-F2CA9E9B-BBEB-4DEB-9A76-BB4C369E9B17Q37828405-5DCA8657-8035-4341-80DF-351DD68FD2BDQ40309976-225BB744-C3C1-445C-9A91-BF63AE22D776Q42093293-6A99ACA9-7B59-4F23-A554-DE421C6316EC
P2860
Cutting edge: delay and reversal of T cell tolerance by intratumoral injection of antigen-loaded dendritic cells in an autochthonous tumor model.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cutting edge: delay and revers ...... an autochthonous tumor model.
@ast
Cutting edge: delay and revers ...... an autochthonous tumor model.
@en
Cutting edge: delay and revers ...... an autochthonous tumor model.
@nl
type
label
Cutting edge: delay and revers ...... an autochthonous tumor model.
@ast
Cutting edge: delay and revers ...... an autochthonous tumor model.
@en
Cutting edge: delay and revers ...... an autochthonous tumor model.
@nl
prefLabel
Cutting edge: delay and revers ...... an autochthonous tumor model.
@ast
Cutting edge: delay and revers ...... an autochthonous tumor model.
@en
Cutting edge: delay and revers ...... an autochthonous tumor model.
@nl
P2093
P2860
P356
P1476
Cutting edge: delay and revers ...... an autochthonous tumor model.
@en
P2093
Ching-Hung Shen
Eileen M Higham
Jianzhu Chen
K Dane Wittrup
P2860
P304
P356
10.4049/JIMMUNOL.1000265
P407
P577
2010-04-28T00:00:00Z